Neutrophils: Musketeers against immunotherapy is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA224493
NCI NIH HHS
Grant: R01 CA221158
NCI NIH HHS
Grant: R01 CA240952
National Institutes of Health
Grant: 5R01CA224493-02
Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs
European Commission
Grant: 221158
Investigating the neural correlates of working memory capacity using functional magnetic resonance imaging and transcranial magnetic stimulation
National Institutes of Health
Grant: 3P30CA082709-16S3
Indiana University Melvin and Bren Simon Cancer Center Support Grant
National Institutes of Health
Grant: 7R01CA221158-02
Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancer
National Institutes of Health
Grant: 1R01CA240952-01A1
Targeting NQO1+ tumor to trigger innate and adaptive immunity
FWCI
2.03
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Additional file 1 of A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors